Cytokine members of the Tumor Necrosis Factor (TNF) Superfamily play key roles in host defense to viral pathogens. In particular, the Lymphotoxin (LT)alpha-betaLTbeta receptor (LTbetaR) system and other closely related cytokines are required for effective immune defenses against cytomegalovirus (CMV), a beta-herpes virus. Both in vitro studies with human CMV and in vivo studies with murine CMV indicate that the LTbetaR system plays a key role in the establishment and maintenance of immunological balance between the host and this persistent virus. Specifically, in vivo activation of the LTbetaR by an agonist anti-LTbetaR antibody can prevent lymphocyte death, restore IFNbeta levels, reorganize lymphoid tissue and extend the survival of MCMVinfected, LTalpha-deficient mice. These results indicate that modulating the LTbetaR pathway in vivo can restore immune balance during this viral infection. Human CMV infection remains a stubborn clinical problem especially in immune compromised (chemotherapy or AIDS) patients, and emerging evidence suggests chronic inflammation, associated with persistent viruses like HCMV, may also contribute to cardiovascular disease. Clinically, there exists a particular need for effective treatment of this virus since the efficacy of anti-viral drugs has been limited by toxicity and viral resistance. Understanding the limitations of currently available anti-viral treatment provides strong impetus to identify novel approaches that will enhance the host's immune responsiveness while at the same time effectively suppressing virus replication. The goal of this proposal is to test the hypothesis that the LTbetaR is a significant factor in host defense to human CMV. To accomplish this 3 specific aims are proposed to investigate the LT cytokine system in CMV infection in a model which most closely resembles human CMV infection.
In specific aim 1, the LTbetaR signaling pathway will be studied using agonistic and antagonistic reagents to provide mechanistic data for studies proposed in specific aims 2 and 3. These experiments will directly test the efficacy of LT(R agonists and antagonists as modulators of CMV infection and in particular the ability of an agonist anti-LTbetaR antibody to ameliorate the infection in under both immunocompetent and immunocompromised conditions. The success of these reagents should validate this novel immunotherapeutic approach as a potential treatment for human CMV infection.? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI057840-04
Application #
7346969
Study Section
Special Emphasis Panel (ZRG1-IHD (01))
Program Officer
Beisel, Christopher E
Project Start
2005-02-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
4
Fiscal Year
2008
Total Cost
$487,966
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Arens, Ramon; Loewendorf, Andrea; Her, Min J et al. (2011) B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence. J Virol 85:390-6
Humphreys, Ian R; Lee, Seung-Woo; Jones, Morgan et al. (2010) Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. Eur J Immunol 40:2762-8
Zhao, Yuan; De Trez, Carl; Flynn, Rachel et al. (2009) The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus. J Immunol 182:6278-86
Arens, Ramon; Wang, Peng; Sidney, John et al. (2008) Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 180:6472-6
Oxford, Kristie L; Eberhardt, Meghan K; Yang, Kai-Wen et al. (2008) Protein coding content of the UL)b'region of wild-type rhesus cytomegalovirus. Virology 373:181-8
Schneider, Kirsten; Loewendorf, Andrea; De Trez, Carl et al. (2008) Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3:67-76
Ware, Carl F (2008) The TNF Superfamily-2008. Cytokine Growth Factor Rev 19:183-6
Sedy, John R; Spear, Patricia G; Ware, Carl F (2008) Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 8:861-73
Humphreys, Ian R; de Trez, Carl; Kinkade, April et al. (2007) Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 204:1217-25
Humphreys, Ian R; Loewendorf, Andrea; de Trez, Carl et al. (2007) OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism. J Immunol 179:2195-202

Showing the most recent 10 out of 12 publications